| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 10/20/2004 | EP0778891B1 Monoclonal recombinant anti-rhesus d (d7c2) antibody |
| 10/20/2004 | EP0734451B1 ENTEROTOXINS OF SHIGELLA FLEXNERI 2a |
| 10/20/2004 | EP0732939B1 Preparation and use of immunoconjugates comprising a VL-chain glycosylated at the Asn in position 18 |
| 10/20/2004 | EP0722461B1 Expression of fusion polypeptides transported out of the cytoplasm without leader sequences |
| 10/20/2004 | EP0668906B1 Method for producing polypeptide via bacterial fermentation |
| 10/20/2004 | EP0658113B1 Isolated nonapeptide derived from mage-3 gene and presented by hla-a1, and uses thereof |
| 10/20/2004 | CN1539018A Surface expression vectors having pgs BCA the gene coding poly-gamma-glutamate synthetase, and method for expression of target protein at the surface of microorganism using the vector |
| 10/20/2004 | CN1539014A Templated molecules and methods for using such molecules |
| 10/20/2004 | CN1539011A Carbohydrates and polyols for dissolving protein crystal |
| 10/20/2004 | CN1538973A Factor VIII separation |
| 10/20/2004 | CN1538854A Mutant forms of cholera holotoxin as adjuvant |
| 10/20/2004 | CN1537952A New alginate monoclone antiboeg and its preparation method and use |
| 10/20/2004 | CN1537951A Method of making deer dry cell protein bioactive poptide using microoprganism fermentation technology |
| 10/20/2004 | CN1172001C Process for efficiently purifying gene engineering bacteria recombination expression product and its use |
| 10/20/2004 | CN1171997C Modified TLE-2-receptor ligands |
| 10/20/2004 | CN1171996C American pig reproduction and respiratory syndrome syndrome (PRRS) virus and its use |
| 10/20/2004 | CN1171903C Wheat high-molecular-weight glutelin subunit monoclonal anitbody and its hybrid tumor cell line |
| 10/20/2004 | CN1171902C Antisercretory factor petides regulating pathological permeability changes |
| 10/20/2004 | CN1171900C Novel, ubiquitous potassium-channel proteins and genes for the same |
| 10/19/2004 | US6806360 Nucleic acids encoding human tissue factor inhibitor |
| 10/19/2004 | US6806351 Nucleotide sequences coding proteins for use in the diagnosis and treatment of hematopoietic or immune disorders |
| 10/19/2004 | US6806086 Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits |
| 10/19/2004 | US6806074 Proteinase inhibitor, precursor thereof and genetic sequences encoding same |
| 10/19/2004 | US6806066 Plasmid which prolongs bacterial viability during fermentation |
| 10/19/2004 | US6806063 Protein conjugate for use in the treatment of blood disorder |
| 10/19/2004 | US6806061 G protein-coupled receptor gene and methods of use therefor |
| 10/19/2004 | US6806059 Nucleotide sequences coding enzymatic polypeptide for use innthe treatment of asthma, and for use in laundry detergent and stain removers |
| 10/19/2004 | US6806058 Comprises biotinylated matrix which binds isotypic regions of immunoglobulins/antibodies; for improving the resolution of detection of multiple proteins and/or cell surface markers |
| 10/19/2004 | US6806053 Cell-signaling assays |
| 10/19/2004 | US6805870 Paramunity inducer based on combinations of poxvirus components, process to prepare it and its use as medicament |
| 10/19/2004 | US6805864 Type I angiotensin II receptor specific monoclonal antibodies and hybridomas |
| 10/19/2004 | CA2323096C Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen |
| 10/19/2004 | CA2282734C Aminopeptidase derived from bacillus licheniformis and process for preparation of natural type proteins |
| 10/19/2004 | CA2059898C Biologically active bacillus thuringiensis isolates and gene encoding a coleopteran-active toxin |
| 10/18/2004 | CA2426115A1 Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots |
| 10/14/2004 | WO2004087914A1 Method of constructing antibody |
| 10/14/2004 | WO2004087911A1 Method of constructing hybridoma producing antigen-specific antibody using single antigen-specific b lymphocyte and method of producing monoclonal antibody |
| 10/14/2004 | WO2004087764A1 Recombinant antibody recognizing dioxin and gene encoding the antibody |
| 10/14/2004 | WO2004087762A1 Antibodies inhibiting tansportation activity of peptide transporter |
| 10/14/2004 | WO2004087730A2 Method for producing diverse libraries of encoded polymers |
| 10/14/2004 | WO2004087210A1 Method of inducing differentiation and proliferating regulatory t cell by anti-cd52 antibody and medicinal composition therefor |
| 10/14/2004 | WO2004087058A2 Targeted mhc class i alpha3 vaccine delivery systems |
| 10/14/2004 | WO2004087055A2 Use of fgf- 18 protein, target proteins and their respective encoding nucleotide sequences to induce cartilage formation |
| 10/14/2004 | WO2004087044A2 Drug target |
| 10/14/2004 | WO2004087038A1 Kit for pharmaceutical use |
| 10/14/2004 | WO2004024063A3 Compositions and methods for the diagnosis and treatment of tumor |
| 10/14/2004 | WO2004021010A3 Method of diagnosing colon and gastric cancers |
| 10/14/2004 | WO2004016769A3 Antibodies directed to monocyte chemo-attractant protein-1 (mcp-1) and uses thereof |
| 10/14/2004 | WO2004016740A3 Humanized rabbit antibodies |
| 10/14/2004 | WO2003089620A3 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 10/14/2004 | WO2003061595A3 Antibodies against and compositions containing new amphetamine derivatives |
| 10/14/2004 | WO2003031475A8 Antibodies against kdr, their production and uses |
| 10/14/2004 | WO2001075067A8 Novel nucleic acids and polypeptides |
| 10/14/2004 | US20040205835 Jak kinases and regulation of cytokine signal transduction |
| 10/14/2004 | US20040205834 System for inducible expression in eukaryotic cells |
| 10/14/2004 | US20040205832 Transgenically produced decorin |
| 10/14/2004 | US20040204578 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 10/14/2004 | US20040204577 Novel peptide-forming enzyme gene |
| 10/14/2004 | US20040204568 Comprises nucleotide sequences coding cell adhesion molecules for use in the diagnosis, prevention and treatment of autoimmune and cell proliferative disorders |
| 10/14/2004 | US20040204565 Use of multivalent chimeric peptide-loaded, MHC/IG molecules to detect, activate or suppress antigen-specific T cell-dependent immune responses |
| 10/14/2004 | US20040204563 Generating transgenic bacteria coding/expressing eschrichia thioredoxin fusion protein for use as diagnostic marker in heterologous gene expression; bioreactors |
| 10/14/2004 | US20040204361 Kdel receptor inhibitors |
| 10/14/2004 | US20040204350 Disease- associated protein |
| 10/14/2004 | US20040204345 Using recombinant zinc finger proteins; use in human therapeutic applications such as cancer therapy and altering plant phenotypes, including disease resistance, fruit ripening |
| 10/14/2004 | US20040204236 Competition entry with limited return messaging |
| 10/14/2004 | US20040203157 Transfroming arabidopsis with expression vector coding genes associated with heat, freeze, salt and drought resistance; using ribonucleoproteins to control effivient gene transcription in plants; bioreactors |
| 10/14/2004 | US20040203144 Using calcium-activated chloride channels (CLCA) to identify modulators for treatment of bronchitis, asthma, cystic fibrosis, chronic obstructive pulmonary disease (COPD) and bronchiectasis |
| 10/14/2004 | US20040203134 involves the profound enzymatic protein hydrolysis of marine animal biomass, whereby cold-water fish wastes are reacted with viscera containing aggressive enzymes that are effective in even mild (slightly alkaline) medium of water |
| 10/14/2004 | US20040203125 recombinant chimera produced using solid phase synthesis; for biosnesors/bioreactors, diagnostic and drugs |
| 10/14/2004 | US20040203118 Polynucleotides and polypeptides of the IFNalpha-14 gene |
| 10/14/2004 | US20040203117 Method of expressing genetically modified protein carrying sugar chain having sialic acid added thereto in insect cells |
| 10/14/2004 | US20040203116 IL-1 eta DNA and polypeptides |
| 10/14/2004 | US20040203102 Antiplasmin cleaving enzyme |
| 10/14/2004 | US20040203099 Conjugate of a transport protein and a protein for modulation of notch signalling |
| 10/14/2004 | US20040203098 Compounds and methods for modulating activation of NF-kappaB |
| 10/14/2004 | US20040203097 Kinases and phosphatases |
| 10/14/2004 | US20040203091 Process for synthesizing protein using cell-free protein synthesis system |
| 10/14/2004 | US20040203090 Biodegradable glucosaminemuramyl peptides for apoptosis modulation |
| 10/14/2004 | US20040203070 Method and means for detecting alcohol consumption |
| 10/14/2004 | US20040203026 preferred cleaving conditions include heating in an acceptable buffer for a time ranging between about 16 and 24 hours at a temperature between about 20 degrees C. and about 37 degrees C |
| 10/14/2004 | US20040203014 Neurotransmisson-associated proteins |
| 10/14/2004 | US20040203001 Methods for identifying human cell lines useful for endogenous gene activation, isolated human cell lines identified thereby, and uses thereof |
| 10/14/2004 | US20040203000 Cell-signaling assays |
| 10/14/2004 | US20040202679 truncated papillomavirus L1 protein consisting of an amino acid sequence having one or more carboxy terminal amino acid residues deleted from a full length L1 amino acid sequence, and amino acid residues from a second protein replacing deleted amino acid residues in the truncated L1 protein. |
| 10/14/2004 | US20040202667 also use in the development of antimalarial drugs and antibodies directed against these Plasmodium proteins. |
| 10/14/2004 | US20040202662 Humanised antibodies |
| 10/14/2004 | US20040202659 A polypeptide encoded by a nucleic acid that encodes a heavy chain, which is able to bind to GPIIb/IIIa, of a human antibody and comprising a CDR3 region; diagnosis, treatment or prevention of autoimmune thrombocytopenic purpura; modulating blood coagulation |
| 10/14/2004 | US20040202657 Humanized anti-CD3 specific antibodies |
| 10/14/2004 | US20040202654 gp100-derived polypeptides that contain both a helper T-cell epitope and a cytotoxic T-cell epitope used to induce antitumor responses in melanoma patients |
| 10/14/2004 | US20040202650 Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA-4 specific antibodies |
| 10/14/2004 | US20040202646 Bifunctional glycoproteins having a modified carbohydrate complement and their use in tumor-selective therapy |
| 10/14/2004 | CA2520861A1 Method for transdifferentiation of non-pancreatic stem cells to the pancreatic pathway |
| 10/14/2004 | CA2520830A1 Method for inducing differentiation and/or proliferating regulatory t cells using anti-cd52 antibodies and pharmaceutical composition therefor |
| 10/14/2004 | CA2520460A1 Use of fgf- 18 protein, target proteins and their respective encoding nucleotide sequences to induce cartilage formation |
| 10/14/2004 | CA2520381A1 Proteolytic and covalent antibodies |
| 10/14/2004 | CA2517102A1 Kit for pharmaceutical use |
| 10/13/2004 | EP1467212A1 Process for differential diagnosis of Alzheimer's denmentia and device therefor |
| 10/13/2004 | EP1466982A1 Pyroglutamyl peptidase and its gene |
| 10/13/2004 | EP1466979A1 Fungus-origin lysyl oxidases |
| 10/13/2004 | EP1466972A1 Nucleotide sequences having activity of controlling translation efficiency and utilization thereof |